研究実績  |  RESULTS ACHIEVEMENT

英文論文

    2005
  • Inukai K, Awata T, Inoue K, Kurihara S, Nakashima Y, Watanabe M, Sawa T, Takata N, Katayama S : Identification of a novel WFS1 mutation (AFF344-345ins) in Japaness patirnts with Wolfram syndrome. Diabetes Res and Clin Pract 69:136-141, 2005.
  • 2005
  • Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, Inoue I, Kawasaki I, Mori K, Yoneya S, Katayama S : Functional VEGT C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Rese Commun. 333:679-685, 2005.
  • 2005
  • Inukai K, Watanabe M, Nakashima Y, Takata N, Isoyama A, Sawa T, Kurihara S, Awata T, Katayama S: Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2005;328:484-90.
  • 2005
  • Kushiyama A, Shojima N, Ogihara T, Inukai K, Sakoda H, Fujishiro M, Fukushima Y, Anai M, Ono H, Horike N, Viana AY, Uchijima Y, Nishiyama K, Shimosawa T, Fujita T, Katagiri H, Oka Y, Kurihara H, Asano T: Resistin like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes and induces diabetes, hyperlipidemia and fatty liver in transgenic mice on a high-fat diet. J Biol Chem. 280(51), 42016-42025, 2005
  • 2005
  • Shojima N, Ogihara T, Inukai K, Fujishiro M, Sakoda H, Kushiyama A, Katagiri H, Anai M, Ono H, Fukushima Y, Horike N, Viana AY, Uchijima Y, Kurihara H, Asano T, Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia 48, 984-992, 2005
  • 2005
  • Inukai K, Watanabe M, Nakashima Y, Sawa T, Takata N, Tanaka M, Kashiwabara H, Yokota K, Suzuki M, Kurihara S, Awata T, Katayama S: Efficacy of Glimepiride in Japanese Type 2 Diabetic Subjects. Diabetes Res. Clin. Pract. 68, 250-257, 2005
  • 2005
  • Inukai K, Nakashima Y, Watanabe M, Takata N, Sawa T, Kurihara S, Awata T, Katayama S:]Regulation of adiponectin receptor gene expression in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 288, E876-882, 2005
  • 2005
  • Iwasaki N, Horikawa Y, Tsuchiya T, Kitamura Y, Nakamura T, Tanizawa Y, OkaY, Hara K, Kadowaki T, Awata T, Honda M, Yamashita K, Oda N, Yu L, Yamada N, Ogata M, Kamatani N, Iwamoto Y, Del Bosque-Plata L, Hayes MG, Cox NJ, Bell GI : Genetic variants in the calpain-10 gene and the development of type 2 diabetesin the Japanese population. J Hum Genet. 2005;50:92-8.
  • 2005
  • Noso S, Ikegami H, Fujisawa T, Kawabata Y, Asano K, Hiromine Y, Tsurumaru M, Sugihara S, Lee I, Kawasaki E, Awata T, Ogihara T : Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes.. Diabetes. 54(12):3582-3586 2005.
  • 2004
  • Awata T, Neda T, Iizuka H, Kurihara S, Ohkubo T, Takata N, Osaki M, Watanabe M, Nakashima Y, Sawa T, Inukai K, Inoue I, Shibuya M, Mori K, Yoneya S, KatayamaS: Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care. 2004;27:2184-90.
  • 2004
  • Inukai K, Nakashima Y, Watanabe M, Kurihara S, Awata T, Katagiri H, Oka Y, Katayama S, ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem. Biophys. Res. Commun. 317, 1075-1079, 2004
  • 2004
  • Inukai K, Shewan AM, Pascoe WS, Katayama S, James DE, Oka Y, Carboxy terminus of glucose transporter GLUT3 contains an apical membrane targeting domain. Mol. Endocrinol.18, 339-349, 2004
  • 2004
  • Inoue I, Katayama S : The possibletherapeutic actions of peroxisome proliferator-activated receptor (PPAR ) agonists, PPAR agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial cells. Curr Drug Targets Cardiovasc Haematol Disord 4(1): 35-52, 2004
  • 2004
  • Takata N, Awata T, Inukai K, Watanabe M, Ohkubo T, Kurihara S, Inaba M, and Katayama S : Pro12Ala Substitution in Peroxisome Proliferator-Activated Receptor2 Is Associated With Low Adiponectin Concentrations in Young Japanese Men. Metabolism 53(12) : 1548-1551, 2004.
  • 2004
  • Katayama S : Tight blood pressure control with ACE inhibitor and /or ARB delays or improves diabetic nephropathy. Nephrology Frontier 3(3) : 230-231,2004.
  • 2004
  • Ushiyama M, Morita T, Kuramochi T, Yagi S, Katayama S: Erectile Dysfunction in Hypertensive Rats Results from Impairment of the Relaxation Evoked by Neurogenic Carbon Monoxide and Nitric Oxide. Hypertens Res 27(4) : 253-261, 2004.
  • 2004
  • Nakajima T, Matsunaga T, Kawai S, Hokari S, Inoue I, Katayama S, Nagata A and Komoda T: Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma. Ann Clin Biochem 41:309-315, 2004.

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1111(代)
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。